financetom
Business
financetom
/
Business
/
Apple Is Sending Alphabet Stock Higher Monday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple Is Sending Alphabet Stock Higher Monday: What's Going On?
Mar 18, 2024 6:26 AM

Alphabet Inc ( GOOG ) shares are trading higher Monday following reports suggesting Apple Inc ( AAPL ) is in discussions to integrate Google Gemini into iPhones.

What To Know: Apple ( AAPL ) and Google ( GOOG ) are in active negotiations over potentially building Google’s Gemini AI engine into the iPhone, according to Bloomberg.

People familiar with the matter reportedly said the discussions are centered around letting Apple ( AAPL ) license Gemini to help power some new features that are planned for the coming iPhone models. The two parties have not worked on terms or finalized exactly how it would be implemented, the people said.

The report indicates that Apple ( AAPL ) has also recently held discussions with OpenAI about potentially using its AI model to power the new phone features.

Apple ( AAPL ) currently has a partnership with Alphabet for the company’s Search product. For years, Google ( GOOG ) has paid Apple ( AAPL ) billions of dollars to make its search engine the default option when a user opens the Safari browser on Apple ( AAPL ) devices.

Both Apple ( AAPL ) and Google ( GOOG ) shares were trading higher following the report. Apple ( AAPL ) shares have lagged behind some of its mega-cap peers in recent months as investors await more information on the company’s AI strategy.

Apple ( AAPL ) has reportedly been testing its own large language model codenamed Ajax, but the company remains behind other big players in the AI space, according to the people. Apple’s Worldwide Developers Conference is set to take place in June and AI is expected to be the key focus.

Alphabet is not due to report earnings again until the end of next month. Analysts currently expect the company to report earnings of $1.51 per share and revenue of $78.58 billion, according to Benzinga Pro.

See Also: Apple Quietly Unveils New Multimodal AI With A Staggering 30B Parameters: Could It Power Text And Vision Features On iPhones?

GOOG Price Action: Alphabet shares were up 4.85% at $149.06 at the time of publication, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lyondellbasell Industries Insider Bought Shares Worth $380,300, According to a Recent SEC Filing
Lyondellbasell Industries Insider Bought Shares Worth $380,300, According to a Recent SEC Filing
Dec 16, 2024
04:17 PM EST, 12/16/2024 (MT Newswires) -- Robin W.T. Buchanan, Director, on December 13, 2024, executed a purchase for 5,000 shares in Lyondellbasell Industries ( LYB ) for $380,300. Following the Form 4 filing with the SEC, Buchanan has control over a total of 18,175 shares of the company, with 18,175 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1489393/000156218024008417/xslF345X05/primarydocument.xml ...
Paylocity Holding Insider Sold Shares Worth $4,138,007, According to a Recent SEC Filing
Paylocity Holding Insider Sold Shares Worth $4,138,007, According to a Recent SEC Filing
Dec 16, 2024
04:17 PM EST, 12/16/2024 (MT Newswires) -- Steven I Sarowitz, 10% Owner, Director, on December 12, 2024, sold 20,421 shares in Paylocity Holding ( PCTY ) for $4,138,007. Following the Form 4 filing with the SEC, Sarowitz has control over a total of 8,885,533 shares of the company, with 8,365,533 shares held directly and 520,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1591698/000159169824000427/xslF345X05/wk-form4_1734383554.xml...
Merus Reports First Person Dosed in Mid-Stage Petosemtamab Trial
Merus Reports First Person Dosed in Mid-Stage Petosemtamab Trial
Dec 16, 2024
04:22 PM EST, 12/16/2024 (MT Newswires) -- Merus (MRUS) said Monday the first person has been dosed in its phase 2 trial assessing petosemtamab in heavily pretreated metastatic colorectal cancer. In preclinical CRC models, petosemtamab consistently demonstrates superior activity compared to cetuximab, a mainstay therapy in mCRC, said Merus Chief Technology Officer John de Kruif. ...
Mama's Creations Fiscal Q3 Earnings Decline, Revenue Increases; Shares Plunge After Hours
Mama's Creations Fiscal Q3 Earnings Decline, Revenue Increases; Shares Plunge After Hours
Dec 16, 2024
04:22 PM EST, 12/16/2024 (MT Newswires) -- Mama's Creations (MAMA) reported fiscal Q3 diluted earnings late Monday of $0.01 per share, down from $0.05 a year earlier. A single analyst surveyed by FactSet expected $0.03. Revenue for the quarter ended Oct. 31 was $31.5 million, up from $28.7 million a year earlier. Four analysts surveyed by FactSet expected $30 million....
Copyright 2023-2026 - www.financetom.com All Rights Reserved